Delivery Order SPE2DB22D1106-SPE2DB25FERP1
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,083.66 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 12, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a pediatric or small-quantity pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation, utilizing AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $11,046.77 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 3, 2025, with completion scheduled for September 4, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen medication on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $2,360.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,979.98 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, issued under a non-competitive, non-set-aside procurement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $8,378.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. The contract, which is unset-aside and competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). Performance of this delivery order will be completed by June 18, 2025, with fulfillment occurring at the company's corporate...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FERP1Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,632.54 delivery order contract to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of June 4, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medical products to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The underlying IDC framework enables the company to fulfill federal medical supply needs for various government healthcare systems, including the Defense Health Agency and U.S. Coast Guard, while supporting DLA's strategic pharmaceutical procurement objectives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/3/25 |